MedPath

Efficacy and outcomes of Lian-Hua Qing-Wen capsule in the treatment of novel coronavirus pneumonia (COVID-19): a medical records based retrospective study

Not Applicable
Recruiting
Conditions
ovel coronavirus disease (COVID-19)
Registration Number
ITMCTR2000003537
Lead Sponsor
920th Hospital of the PLA Joint Logistics Support Force
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients who were aged 18 years or older and laboratory-confirmed with COVID-19 by nucleic acid assay

Exclusion Criteria

1. Missing pathogen or chest computerized tomography (CT) detection;
2. Severe comorbidities, such as advanced malignancy, congenital heart disease or autoimmune diseases.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Death;Hospital discharged;
Secondary Outcome Measures
NameTimeMethod
Chest CT;Laboratory examinations;
© Copyright 2025. All Rights Reserved by MedPath